Ultrasonido Diagnostico de Alta Especialidad y Biopsias.

04/06/2026

Jueves.

16/05/2026

Malignant liver cancers such as hepatocellular carcinoma (HCC) are a major global health challenge. In 2020, approximately 830,200 people worldwide died from HCC alone; by 2040, deaths could increase by 55%. The first-line curative treatment for small (≤3–5 cm) hepatic tumors is percutaneous ablation (PTA), which includes microwave and radiofrequency ablation.

Compared with surgical resection, PTA has a superior safety profile. However, most existing safety data are outdated. Ablation technology and procedural complexity have evolved and contemporary benchmarks for procedure-related mortality and major adverse events are needed.

To address this gap, Gary Doppelt, MD, St-Éloi University Hospital, Montpellier, and Caremeau University Hospital, Nîmes, France, and colleagues published a meta-analysis in Radiology of 4,149 patients who underwent PTA of malignant liver tumors across 49 studies. They found that 90-day procedure-related mortality was near zero and the major complication rate was only 3%.

“These results support PTA as a lowrisk treatment with consistent safety outcomes, reinforcing its central role as a cornerstone technique within the multidisciplinary management of liver malignant neoplasms,” the authors said.

Read the full article from Radiology (RSNA Journal): https://bit.ly/4wqUR7B

14/05/2026

Bienvenido nuestro nuevo equipo que nos ayudara a brindarte un mejor servicio. Con mejor definicion y mas funciones especificas como elastografia hepatica, mama, testicular, tiroides, 3d, 4d y estudios contrastados.
Pensando siempre en tu diagnostico.

22/04/2026

22/04/2026

Acute chest pain is a common concern in the emergency department (ED), but accurate diagnosis of acute coronary syndrome (ACS) is challenging. Although ACS is present in only 5% to 10% of patients with chest pain, most undergo extensive evaluation to avoid the clinical and legal ramifications of misdiagnosis.

Coronary CT angiography (CCTA) is the first-line modality for assessing stable chest pain of suspected coronary origin. According to a recent Radiology review, a logical next step is expanding CCTA to help triage appropriate patients with possible ACS.

Authors led by Rozemarijn Vliegenthart, MD, PhD, from the University of Groningen, the Netherlands, describe the current role of CCTA in managing different risk populations and optimizing resources. CCTA is a safe, reliable tool for triaging patients at low risk for ACS, they concluded. However, its role in triaging patients with higher risk is less certain and warrants more evaluation.

“Integrating CT-based plaque features, CT fractional flow reserve, and CT perfusion, along with high-sensitivity cardiac troponins, may enhance diagnostic pathways and improve triage effectiveness in the ED,” the authors summarized.

Read the full Radiology (RSNA Journal) article, “Coronary CT Angiography for Acute Chest Pain in the Emergency Department.” https://bit.ly/3ZHK1Lh

02/04/2026

Se les informa a nuestros pacientes que tendremos cerrado los Dias 3 y 4 de Abril 2026. (Viernes y sabado)
Lunes horario normal.

18/03/2026

Biopsia de tumor suprarrenal derecho, con reporte histopatologico positivo para linfoma tipo B, marcadores de inmunohistoquimica CD20, MUM1.

28/01/2026

Biopsia prostatica transrectal, APE elevado, de ecogenocidad heterogenea y aumento de tamano.
En espera de reporte histopatologico.

15/10/2025

Ultrasonido diagnóstico de alta especialidad.
Certificado por el Consejo Mexicano de Radiologia e Imagen.

Ultrasonido portatil (servicio a domicilio).
Biopsias guiadas por ultrasonido.

01/10/2025

Este mes de Octubre en la lucha contra el cancer de mama, tendremos promocion de Ultrasonido de mama en $650.
Ultrasonido de mama y pelvico femenino $1200.
Cita previa.
8681538139.